Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification.
about
Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and RecommendationsNew GOLD classification: longitudinal data on group assignment.Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017.Comparison of Korean COPD guideline and GOLD initiative report in term of acute exacerbation: a validation study for Korean COPD guideline.Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial.Prevalence and risk factors of asymptomatic peripheral arterial disease in patients with COPD in Taiwan.Finding the best thresholds of FEV1 and dyspnea to predict 5-year survival in COPD patients: the COCOMICS study.The effect of comorbidities on COPD assessment: a pilot studySix-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.Evaluation of the COPD Assessment Test and GOLD patient types: a cross-sectional analysis.Influence of pulmonary emphysema on COPD assessment test-oriented categorization in GOLD document.Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.Physical Activity Characteristics across GOLD Quadrants Depend on the Questionnaire Used.Association of MicroRNA-196a2 Variant with Response to Short-Acting β2-Agonist in COPD: An Egyptian Pilot Study.Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease.Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary diseaseExternal validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort)The Health of India's Elderly Population: A Comparative Assessment Using Subjective and Objective Health OutcomesCategorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study.Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trialBiobehavioral Prognostic Factors in Chronic Obstructive Pulmonary Disease: Results From the INSPIRE-II TrialResting and Post-Exercise Ankle-Brachial Index Measurements to Diagnose Asymptomatic Peripheral Arterial Disease in Middle Aged and Elderly Chronic Obstructive Pulmonary Disease Patients: A Pilot Study.Prognostic utility of the 2011 GOLD classification and other multidimensional tools in Asian COPD patients: a prospective cohort study.Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George's Respiratory Questionnaire cutoff 25 (and 20) aThe use of health status questionnaires in the management of chronic obstructive pulmonary disease patients in clinical practice.Moving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine--a critical view.An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.Effects of whole body vibration on pulmonary function, functional exercise capacity and quality of life in people with chronic obstructive pulmonary disease: a systematic review.Effect of Tiotropium on Outcomes in Patients With COPD, Categorized Using the New GOLD Grading System: Results of the UPLIFT® Randomized Controlled Trial.Comparing the 2007 and 2011 GOLD Classifications as Predictors of all-Cause Mortality and Morbidity in COPD.Classification of Airflow Limitation Based on z-Score Underestimates Mortality in Patients with Chronic Obstructive Pulmonary Disease.The association of tidal EFL with exercise performance, exacerbations, and death in COPDStructure and functional impact of seed region variant in MIR-499 gene family in bronchial asthmaPrognostic Indices and Mortality Prediction in COPD Caused by Biomass Smoke Exposure.GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway.A passenger strand variant in miR-196a2 contributes to asthma severity in children and adolescents: A preliminary study.Evaluation of clinical variables according to follow-up times in COPD: results from ON-SINT cohort.Changes in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in China.
P2860
Q30245662-F6F8C526-5DC1-4121-B9F3-BFA5CB64F9DEQ30732307-23A881F9-433C-4067-9125-76A4DC4C78ADQ33705840-076AFE03-17F5-47CD-BD9A-25E879C62A68Q33718748-0E771F90-60F0-4E23-9888-8E65EEF54E7AQ34029980-2D0736D3-170B-4B70-9DB7-C584946DF9B4Q34469716-B206E56A-296E-423D-8A2D-95F17FB2B8A7Q34746281-AE237D19-75AB-4D4C-BF12-6A54748186ECQ35108231-57F89405-CEBB-4FB7-9987-2CDCD4E6C5A2Q35142397-D8D667BB-8B4A-4C34-B7DC-6A0EB3572826Q35565089-C1EAEC32-0A09-419A-8F35-64117742FCEFQ35683840-03ED26D2-0EC7-4B77-9246-90D35840E1D8Q35780996-A80C7444-596E-4546-A201-B77B993ADEEAQ35915157-5AE7EF99-433A-4B95-A49E-B580179ABDA5Q35956001-A9172EFB-A4EC-4095-AE1F-B53C519536AAQ35978993-09986749-1EF2-460D-8CB0-967175AB5D1DQ35981939-7FC8BEF4-2390-4F65-8E30-C13D16C132D9Q36037006-F5D8ADF1-B22F-42CD-8C6E-EA294E14FBCFQ36052363-71C4B7A8-F170-4E6B-B225-E6AB1C28ED64Q36190129-062B7212-C4E9-417B-818C-F3ADAB3B3CDAQ36278058-5EA29937-4D7A-439C-8DC3-4CB2F0F830E7Q36303220-06DFF768-77B2-4E13-BDDB-6A0FE295139BQ36498764-34CB9A9A-0DDD-48F7-B3C6-024483637E88Q36535142-D253B032-DDBF-4A19-9F7F-50A6B2BB262FQ36658551-9BD0DD25-9E93-4D51-9140-798AACFCF66BQ36858183-67D933E6-CEF8-446C-BB03-810C1B7E9AADQ36926496-40051299-237C-4159-91D9-4A360D3BCD77Q38217416-9718B6DA-EAED-443D-B9D9-FEF605C0055AQ38219063-6D0438C8-84A5-484C-B3B8-EA654DB23975Q38399184-F0AFDFB2-450A-4106-8381-DB08210B8B84Q38514299-E1AEE38A-828A-4B53-AEFE-477EFF4B71DEQ38604665-C058C1E4-671E-4D6A-A2D3-85E7A0CCC21CQ39576261-44CA22CE-3DD1-4439-967A-A899E894D3CBQ40287615-B56A1274-879F-4B93-A0D2-4BF679D9C657Q41185075-3AB498A2-215E-4D91-BCAB-832A23265A62Q41466720-5AACA905-571A-4231-8294-1E44903B62CCQ46735568-BFC46F21-83D8-495A-A3F9-7B076A9AE542Q46900590-FB9968AA-21FC-4D30-BE17-E7B674DC74BCQ46931778-59D16E64-FCD7-407F-BA37-5D3C816B0091Q47131947-EF1B70C8-910A-41DB-97FB-8BD0D7D5B838Q47150225-64378EB4-3638-4307-B89B-68089081DB06
P2860
Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Distribution and prognostic va ...... isease grading classification.
@en
Distribution and prognostic va ...... isease grading classification.
@nl
type
label
Distribution and prognostic va ...... isease grading classification.
@en
Distribution and prognostic va ...... isease grading classification.
@nl
prefLabel
Distribution and prognostic va ...... isease grading classification.
@en
Distribution and prognostic va ...... isease grading classification.
@nl
P2093
P50
P356
P1433
P1476
Distribution and prognostic va ...... Disease grading classification
@en
P2093
Bartolome R Celli
Ciro Casanova
Jose M Marin
Juan J Soler-Cataluña
Pere Almagro
P304
P356
10.1378/CHEST.12-1053
P407
P50
P577
2013-03-01T00:00:00Z